Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ilyang Pharmaceutical Co., Ltd.

Latest From Ilyang Pharmaceutical Co., Ltd.

Korea Steps Up Reimbursement For Serious Diseases

South Korea’s government is continuing to step up support to reduce the financial burden on patients suffering from four serious diseases. In its latest plan, the health ministry has increased reimbursement of therapies for pancreatic cancer, chronic myeloid leukemia, soft tissue sarcoma and lymphoma.

BioPharmaceutical Asia Pacific

Korea’s Ilyang Pharm, LegoChem Boosted By Anti-Cancer Therapy Deals

South Korean pharmas advance in the oncology space as Ilyang Pharm lets Colombia's Biopas sell its novel leukemia therapy Supect in 10 Latin American countries, while LegoChem Biosciences links with Fosun Pharma for development and commercialization of its antibody-drug conjugate as an anticancer therapy for the Greater China region.

BioPharmaceutical South Korea

Korea Chooses New Group Of Innovators For R&D Support

South Korea’s Ministry of Health and Welfare has unveiled a list of companies that will be designated as innovative pharma firms for the next three years and thus eligible to receive financial and tax incentives to boost their R&D activities.

BioPharmaceutical South Korea

New Long Term Data Add to Ilyang CML Drug Promise

South Korea's mid-size pharma firm Ilyang Pharm has presented promising new clinical results for its leukemia therapy Supect (radotinib; IY5511), which is the first original drug for the disease to be developed in Asia.

BioPharmaceutical South Korea
See All

Company Information

  • Industry
  • Pharmaceuticals